The pathogenetic pathway involving NOD2 in increasing the risk of developing CRC was clarified by Udden et al. In fact, these authors demonstrated that NOD2-deficient mice are highly susceptible to experimental colorectal tumorigenesis independent of gut microbial dysbiosis. Here, NOD2 is linked to colorectal carcinoma.